Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

NCT00451555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: enzastaurin
DRUG: placebo
DRUG: fulvestrant

Sponsor

Eli Lilly and Company